Perfusion process for CHO cell producing monoclonal antibody: Comparison of methods to determine optimum cell specific perfusion rate

被引:5
|
作者
Maria, Sophie [1 ,3 ]
Bonneau, Laurent [1 ]
Fould, Benjamin [2 ,4 ]
Ferry, Gilles [2 ]
Boutin, Jean Albert [2 ,5 ]
Cabanne, Charlotte [1 ]
Santarelli, Xavier [1 ]
Joucla, Gilles [1 ]
机构
[1] Univ Bordeaux, CNRS, Bordeaux INP, CBMN,UMR 5248, F-33600 Pessac, France
[2] Inst Rech SERVIER, Pole Expertise Biotechnol Chim Biol, 125 chemin Ronde, F-78290 Croissy Sur Seine, France
[3] Ingesciences, 2 chemin Arestieux, F-33610 Cestas, France
[4] Vetoquinol SA, 37 Rue Victoire, F-75009 Paris, France
[5] Univ Normandy, Lab Neuronal & Neuroendocrine Differentiat & Commu, INSERM U1239, Rouen, France
关键词
CHO cell culture; Anti-IL8 monoclonal antibody; Perfusion; Spin tubes; Cell specific perfusion rate; Bioreactor; HIGH-DENSITY; FED-BATCH; CULTURE; GLYCOSYLATION; OPTIMIZATION; BIOREACTORS; GLYCATION; VARIANTS; TFF; ATF;
D O I
10.1016/j.bej.2022.108779
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Over twenty-five years ago, perfusion was applied to mammalian cells to produce therapeutic proteins, mainly sensitive ones. Nowadays, other issues such as process intensification make perfusion attractive again. However, it is a complex process to set up compared to the classical fed-batch approach. In this paper, we compared three culture methods to determine the perfusion process parameters for a CHO cell line producing a monoclonal antibody. The push-to-low (PTL) and perfusion-without-bleeding (PWB) methods were performed in bioreactors equipped with a cell retention device, while the semi-perfusion (SP) method was performed in spin tubes. In our culture conditions, the PTL reference method, performed at steady state, indicated a minimum cell specific perfusion rate (CSPRmin) estimated at 100 pL.cell(-1).day(-1). The PWB and SP methods led to lower CSPRmin estimations related to lower cell metabolic fluxes. We therefore propose a three-step approach to determine the perfusion parameters: (i) SP screening method to estimate the optimum medium and temperature, then (ii) PWB run to determine both the growth rate and the maximum cell concentration and finally, (iii) the perfusion process can be operated according to the previously determined parameters, with a final adjustment of the CSPRmin.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Modulation and Modeling of Monoclonal Antibody N-Linked Glycosylation in Mammalian Cell Perfusion Reactors
    Karst, Daniel J.
    Scibona, Ernesto
    Serra, Elisa
    Bielser, Jean-Marc
    Souquet, Jonathan
    Stettler, Matthieu
    Broly, Herve
    Soos, Miroslav
    Morbidelli, Massimo
    Villiger, Thomas K.
    BIOTECHNOLOGY AND BIOENGINEERING, 2017, 114 (09) : 1978 - 1990
  • [22] HYBRIDOMA GROWTH AND ANTIBODY-PRODUCTION AS A FUNCTION OF CELL-DENSITY AND SPECIFIC GROWTH-RATE IN PERFUSION CULTURE
    BANIK, GG
    HEATH, CA
    BIOTECHNOLOGY AND BIOENGINEERING, 1995, 48 (03) : 289 - 300
  • [23] Transitioning from a daily cell bleed perfusion process to a continuous, automated bleed process using a mAb-expressing CHO cell line
    McInnis, Patrick
    Rank, Doug
    Phillips, Michael
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [24] Automation of high CHO cell density seed intensification via online control of the cell specific perfusion rate and its impact on the N-stage inoculum quality
    Schulze, Markus
    Lemke, Johannes
    Pollard, David
    Wijffels, H. Rene
    Matuszczyk, Jens
    Martens, E. Dirk
    JOURNAL OF BIOTECHNOLOGY, 2021, 335 : 65 - 75
  • [25] Isotope labeling to determine the dynamics of metabolic response in CHO cell perfusion bioreactors using MALDI-TOF-MS
    Karst, Daniel J.
    Steinhoff, Robert F.
    Kopp, Marie R. G.
    Soos, Miroslav
    Zenobi, Renato
    Morbidelli, Massimo
    BIOTECHNOLOGY PROGRESS, 2017, 33 (06) : 1630 - 1639
  • [26] A Stable CHO K1 Cell Line for Producing Recombinant Monoclonal Antibody Against TNF-α
    Gupta, Kritika
    Modi, Deepak
    Jain, Ratnesh
    Dandekar, Prajakta
    MOLECULAR BIOTECHNOLOGY, 2021, 63 (09) : 828 - 839
  • [27] Analyzing Clonal Variation of Monoclonal Antibody-Producing CHO Cell Lines Using an In Silico Metabolomic Platform
    Ghorbaniaghdam, Atefeh
    Chen, Jingkui
    Henry, Olivier
    Jolicoeur, Mario
    PLOS ONE, 2014, 9 (03):
  • [28] A Stable CHO K1 Cell Line for Producing Recombinant Monoclonal Antibody Against TNF-α
    Kritika Gupta
    Deepak Modi
    Ratnesh Jain
    Prajakta Dandekar
    Molecular Biotechnology, 2021, 63 : 828 - 839
  • [29] CELL-CYCLE KINETICS AND MONOCLONAL-ANTIBODY PRODUCTIVITY OF HYBRIDOMA CELLS DURING PERFUSION CULTURE
    PARK, SH
    RYU, DDY
    BIOTECHNOLOGY AND BIOENGINEERING, 1994, 44 (03) : 361 - 367
  • [30] Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process
    Liu, Xinrong
    Chen, Ying
    Zhao, Yiwei
    Liu-Compton, Virginia
    Chen, Wesley
    Payne, Gillian
    Lazar, Alexandru C.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 174 : 500 - 508